阿托伐他汀治疗高血压伴不稳定型心绞痛临床效果分析
|
摘要
目的:研究分析阿托伐他汀治疗高血压伴不稳定型心绞痛的临床治疗效果。方法:选取我院2015年4月-2016年5月接收的高血压伴不稳定性心绞痛患者62例,平均分为两组,对照组使用苯磺酸氨氯地平片进行治疗,观察组在对照组的基础上给予阿托伐他汀钙片进行治疗,观察两组患者的临床治疗效果。结果:治疗后,两组患者的收缩压与舒张压情况明显低于治疗前,比较差异有统计学意义(P <0.05),两组患者之间的血压情况比较差异无统计学意义(P> 0.05);观察组患者心绞痛发作的时间与频率均少于对照组,比较差异有统计学意义(P <0.05)。结论:对高血压伴不稳定型心绞痛患者进行分析,阿托伐他汀治疗的临床效果显著,更够提高患者的治疗有效率,值得在临床上推广。
Objective: To study and analyze the clinical efficacy of atorvastatin on hypertension and unstable angina. Methods: 62 cases were divided into two groups. The control group was treated with amlodipine besylate tablets. The observation group was treated with atorvastatin more. The clinical efficacy in two groups was observed. Results: After treatment, the systolic pressure and diastolic pressure in two groups were significantly lower than before treatment, with statistically significant differences(P<0.05). There was no statistically significant difference in blood pressure between two groups(P>0.05). The time and frequency of angina attack in the observation group were less than those in the control group, with a statistically significant difference(P<0.05). Conclusion: Atorvastatin shows a significant effect, can improve the efficacy, and is worth popularizing in clinic.
Objective: To study and analyze the clinical efficacy of atorvastatin on hypertension and unstable angina. Methods: 62 cases were divided into two groups. The control group was treated with amlodipine besylate tablets. The observation group was treated with atorvastatin more. The clinical efficacy in two groups was observed. Results: After treatment, the systolic pressure and diastolic pressure in two groups were significantly lower than before treatment, with statistically significant differences(P<0.05). There was no statistically significant difference in blood pressure between two groups(P>0.05). The time and frequency of angina attack in the observation group were less than those in the control group, with a statistically significant difference(P<0.05). Conclusion: Atorvastatin shows a significant effect, can improve the efficacy, and is worth popularizing in clinic.
引文
[1]郭欣,夏瑞丰,卜颖,等.氨氯地平阿托伐他汀治疗原发性高血压合并不稳定型心绞痛的疗效观察[J].中国医药指南,2013,11(24):128-130.
[2]向阳,何小霞.阿托伐他汀治疗高血压伴不稳定型心绞痛的临床观察[J].中国药房,2015,26(33):4636-4638.
[3]翁军华.应用通心络胶囊联合阿托伐他汀治疗冠心病不稳定型心绞痛的效果分析[J].当代医药论丛,2015,13(3):148-149.
[4]张爱荣.氨氯地平阿托伐他汀钙片治疗高血压合并不稳定心绞痛的临床[J].现代养生,2015,6(12):51.
[5]肖丹.用阿托伐他汀和低分子肝素钙治疗不稳定型心绞痛的效果分析[J].当代医药论丛, 2016,14(14):9-10.
[6]陆卫华,李刚,杨剑虹,等.不同剂量阿托伐他汀治疗不稳定型心绞痛的临床效果分析[J].西南国防医药,2016,26(3):244-246.
[7]杨彦立.阿托伐他汀与曲美他嗪联合治疗不稳定型心绞痛的临床效果观察[J].世界中医药,2015,9(a02):1390-1391.
[8]李辉,赵凯.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床研究[J].实用药物与临床,2017,20(1):56-59.
[9]李翔,高毅滨,郑文武.红花黄色素联合阿托伐他汀治疗不稳定型心绞痛的临床研究[J].现代药物与临床,2016,31(9):1360-1364.
[10]冯艳林,冯艳惠.阿托伐他汀联合替格瑞洛治疗不稳定型心绞痛的临床疗效观察[J].实用心脑肺血管病杂志,2015,23(11):62-64.
[2]向阳,何小霞.阿托伐他汀治疗高血压伴不稳定型心绞痛的临床观察[J].中国药房,2015,26(33):4636-4638.
[3]翁军华.应用通心络胶囊联合阿托伐他汀治疗冠心病不稳定型心绞痛的效果分析[J].当代医药论丛,2015,13(3):148-149.
[4]张爱荣.氨氯地平阿托伐他汀钙片治疗高血压合并不稳定心绞痛的临床[J].现代养生,2015,6(12):51.
[5]肖丹.用阿托伐他汀和低分子肝素钙治疗不稳定型心绞痛的效果分析[J].当代医药论丛, 2016,14(14):9-10.
[6]陆卫华,李刚,杨剑虹,等.不同剂量阿托伐他汀治疗不稳定型心绞痛的临床效果分析[J].西南国防医药,2016,26(3):244-246.
[7]杨彦立.阿托伐他汀与曲美他嗪联合治疗不稳定型心绞痛的临床效果观察[J].世界中医药,2015,9(a02):1390-1391.
[8]李辉,赵凯.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床研究[J].实用药物与临床,2017,20(1):56-59.
[9]李翔,高毅滨,郑文武.红花黄色素联合阿托伐他汀治疗不稳定型心绞痛的临床研究[J].现代药物与临床,2016,31(9):1360-1364.
[10]冯艳林,冯艳惠.阿托伐他汀联合替格瑞洛治疗不稳定型心绞痛的临床疗效观察[J].实用心脑肺血管病杂志,2015,23(11):62-64.